Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Canakinumab vs Red Yeast Rice: Red Yeast Rice has the stronger overall evidence (7.8 vs 4/10); they're alternatives for reduce inflammation — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Red Yeast Rice wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
15 of 16 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Canakinumab and Red Yeast Rice have evidence — compare verdict strength side-by-side.
A prescription biologic, not self-administered for longevity. Approved CAPS dosing is 150 mg subcutaneously every 8 weeks (weight-adjusted in children). The CANTOS cardiovascular regimen was 150 mg subcutaneously every 3 months. There is NO established off-label longevity protocol, and cost is prohibitive.
any
Subcutaneous injection (clinician-administered)
1200-2400mg providing 10mg monacolin K
Evening (cholesterol synthesis peaks at night)
Standardized extract with verified monacolin K content
Months to years
Weeks
Trial endpoints
Throughout use
8-12 weeks
8-12 weeks
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
The New England journal of medicine (2017) · Rct · n=10061
CANTOS: randomized, double-blind, placebo-controlled trial in ~10,000 post-MI patients with elevated hsCRP
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
Lancet (2017) · Rct
Exploratory analysis of the CANTOS cohort — incident and fatal lung cancer as pre-specified secondary endpoints
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial.
Lung cancer (Amsterdam, Netherlands) (2024) · Rct · n=237
CANOPY-2: phase 3 randomized, double-blind trial in advanced non-small-cell lung cancer
Efficacy and Safety of Armolipid Plus(®): An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Nutrients (2021) · Meta analysis · n=1050
Armolipid Plus® was well tolerated.
Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis
The consumption of RYR extract by people with hypercholesterolemia was associated with statistically significant reduction in total cholesterol and LDL-C, whereas it was not associated with an increase in life-threatening side effects.
Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis
Journal of dietary supplements (2024) · Meta analysis · n=4838
Products with berberine alone had less robust effects on TC (MD -12.08 mg/dL [95%CI: -21.79 to -2.37]), LDL (MD -9.26 mg/dL [95%CI: -20.31 to 1.78]), and HDL (MD 1.38 mg/dL [95%CI: -1.27 to 4.03]) but TG effects were similar (MD -17.40 mg/dL [95%CI: -32.57 to -2.23]).
Based on RCT showing 16.77% reduction with 3mg and 26.46% reduction with 10mg monacolin K. Conservative effectiveness scaling due to limited dose-response data and variable study quality noted in meta-analyses.
AI-estimated from published studies. Interpret as directional guidance.
Red Yeast Rice has a higher evidence score (7.8/10 vs 4/10) and wins in 2 of 3 categories.
For reduce inflammation, Red Yeast Rice has a higher relevance score (90 vs 62).
No known interactions between Canakinumab and Red Yeast Rice have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.